Biodesix (BDSX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 19, 2026, to be held virtually for all stockholders of record as of March 23, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of two Class III directors to serve until the 2029 annual meeting: Jean Franchi and Hany Massarany.

• Advisory vote to approve compensation of named executive officers.

• Advisory vote on the frequency of executive compensation votes, with the board recommending every 1 year.

• Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.

• Consideration of other business properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting for all director nominees and all proposals.